common News newsbot.ch

Wirtschaft »

Roche to present results of first prospective trial using blood-based next generation sequencing which successfully identifies people for treatment with Alecensa

2019-09-30 07:20:03


Wirtschaft »

Roche to present new and updated data at ESMO 2019 reinforcing the use of Alecensa in the first-line setting for advanced ALK-positive non-small cell lung cancer

Roche to present new and updated data at ESMO 2019 reinforcing the use of Alecensa in the first-line setting for advanced ALK-positive non-small cell lung cancer

2019-09-28 06:20:30


Wirtschaft »

Roche’s Tecentriq in combination with Avastin shows encouraging results in Phase Ib study of people with unresectable hepatocellular carcinoma

2019-09-27 14:20:09


Wirtschaft »

FDA approves cobas Babesia, Roche’s first whole blood test for donor screening

2019-09-20 07:40:10


Wirtschaft »

Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis

2019-09-13 13:20:50


Wirtschaft »

Roche’s satralizumab significantly reduced relapse risk in second  positive phase III study for neuromyelitis optica spectrum

Roche’s satralizumab significantly reduced relapse risk in second positive phase III study for neuromyelitis optica spectrum

2019-09-12 13:20:00


Wirtschaft »

Roche presents new OCREVUS (ocrelizumab) biomarker data that increase understanding of disease progression in multiple sclerosis at ECTRIMS

2019-09-10 05:40:12


Wirtschaft »

European Commission approves Roche’s new Tecentriq-based combination therapy as an initial treatment for most common form of advanced lung cancer

2019-09-06 06:20:00


Wirtschaft »

Roche to present pivotal data for satralizumab in neuromyelitis optica spectrum disorder and six-year OCREVUS data in multiple sclerosis at ECTRIMS

2019-09-04 06:40:12


Wirtschaft »

Positive phase III results show Xofluza reduces risk of developing flu after contact with an infected person by 86%

2019-09-02 22:40:14


Wirtschaft »

Roche launches VENTANA PD-L1 (SP142) Assay in CE markets as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq

2019-08-29 07:40:16


Wirtschaft »

FDA approves Roche’s Rozlytrek (entrectinib) for people with ROS1-positive, metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumours

2019-08-16 16:40:40


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

2019-07-31 09:24:45


Wirtschaft »

Roche receives CHMP positive opinion for new Tecentriq-based combination therapy as an initial treatment for most common form of advanced lung cancer

2019-07-26 11:20:11


Wirtschaft »

Roche presents a broad range of data for Hemlibra demonstrating continued benefits for people with haemophilia A at the ISTH 2019 Congress

Roche presents a broad range of data for Hemlibra demonstrating continued benefits for people with haemophilia A at the ISTH 2019 Congress

2019-07-09 09:20:15


Wirtschaft »

FDA grants Roche’s Polivy accelerated approval for people with previously treated aggressive lymphoma

2019-06-11 14:40:06


Wirtschaft »

Roche and Spark Therapeutics, Inc. receive Request for Additional Information from FTC under Hart-Scott-Rodino Act and announce extension of tender offer for shares of Spark Therapeutics, Inc.

2019-06-10 12:40:00


Wirtschaft »

Pivotal phase III CLL14 results for Venclexta/Venclyxto in combination with Gazyva/Gazyvaro for chronic lymphocytic leukaemia presented at ASCO 2019 and published in the New England Journal of Medicine

2019-06-04 19:20:00


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

2019-05-14 05:20:02


Wirtschaft »

Roche presents data from the risdiplam pivotal FIREFISH and SUNFISH studies in spinal muscular atrophy at the 2019 AAN Annual Meeting

Roche presents data from the risdiplam pivotal FIREFISH and SUNFISH studies in spinal muscular atrophy at the 2019 AAN Annual Meeting

2019-05-07 06:20:00



Suchresultate als RSS-Feed